TreeWAS – Variant ID: rs35349669

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.946	0.054
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.950	0.050
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.953	0.047
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.954	0.045
Y45.0 Opioids and related analgesics	0.000	0.957	0.043
T46.1 Calcium-channel blockers	0.000	0.957	0.043
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.964	0.036
T46.7 Peripheral vasodilators	0.000	0.964	0.036
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.964	0.036
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.964	0.035
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.967	0.033
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.971	0.029
C45.9 Mesothelioma, unspecified	0.000	0.976	0.024
C45 Mesothelioma	0.000	0.977	0.023
C45.0 Mesothelioma of pleura	0.000	0.977	0.023
C45.7 Mesothelioma of other sites	0.000	0.979	0.021
W19.2 School, other institution and public administrative area	0.018	0.982	0.000
C45.2 Mesothelioma of pericardium	0.000	0.983	0.017
C45.1 Mesothelioma of peritoneum	0.000	0.983	0.017
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.000	0.986	0.014
C85.1 B-cell lymphoma, unspecified	0.013	0.987	0.000
R39.1 Other difficulties with micturition	0.000	0.987	0.013
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.988	0.012
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.000	0.988	0.012
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.989	0.011
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.989	0.011
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.989	0.010
C48.2 Peritoneum, unspecified	0.000	0.990	0.010
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.990	0.010
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.990	0.010
I42.1 Obstructive hypertrophic cardiomyopathy	0.010	0.990	0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.000	0.990	0.010
C46 Kaposi's sarcoma	0.000	0.990	0.010
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.010	0.990	0.000
C49 Malignant neoplasm of other connective and soft tissue	0.000	0.990	0.010
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.990	0.010
C48.0 Retroperitoneum	0.000	0.991	0.009
M06.9 Rheumatoid arthritis, unspecified	0.000	0.991	0.009
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.991	0.009
C48.1 Specified parts of peritoneum	0.000	0.991	0.009
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.991	0.009
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.991	0.009
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.991	0.009
I42 Cardiomyopathy	0.009	0.991	0.000
T43.2 Other and unspecified antidepressants	0.000	0.991	0.009
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.991	0.009
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.000	0.991	0.009
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.991	0.009
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.991	0.009
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.991	0.009
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.991	0.009
I42.2 Other hypertrophic cardiomyopathy	0.009	0.991	0.000
I42.9 Cardiomyopathy, unspecified	0.009	0.991	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.991	0.009
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.991	0.009
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.991	0.009
J35.0 Chronic tonsillitis	0.000	0.992	0.008
T43.6 Psychostimulants with abuse potential	0.000	0.992	0.008
T47.0 Histamine H(2)-receptor antagonists	0.000	0.992	0.008
N75.0 Cyst of Bartholin's gland	0.008	0.992	0.000
C49.0 Connective and soft tissue of head, face and neck	0.000	0.992	0.008
C49.6 Connective and soft tissue of trunk, unspecified	0.000	0.992	0.008
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.000	0.992	0.008
T38.9 Other and unspecified hormone antagonists	0.000	0.992	0.008
T38.7 Androgens and anabolic congeners	0.000	0.992	0.008
T38.4 Oral contraceptives	0.000	0.992	0.008
T38.2 Antithyroid drugs	0.000	0.992	0.008
T38.0 Glucocorticoids and synthetic analogues	0.000	0.992	0.008
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.992	0.008
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.992	0.008
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.992	0.008
C49.5 Connective and soft tissue of pelvis	0.000	0.992	0.008
T43.9 Psychotropic drug, unspecified	0.000	0.992	0.008
T47.2 Stimulant laxatives	0.000	0.992	0.008
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.992	0.008
T37.5 Antiviral drugs	0.000	0.992	0.008
T37.4 Anthelminthics	0.000	0.992	0.008
T37.3 Other antiprotozoal drugs	0.000	0.992	0.008
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.992	0.008
T37.1 Antimycobacterial drugs	0.000	0.992	0.008
T37.0 Sulphonamides	0.000	0.992	0.008
C49.4 Connective and soft tissue of abdomen	0.000	0.992	0.008
I42.4 Endocardial fibroelastosis	0.008	0.992	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.992	0.007
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.992	0.007
T47.7 Emetics	0.000	0.992	0.007
T47.6 Antidiarrhoeal drugs	0.000	0.992	0.007
T47.5 Digestants	0.000	0.992	0.007
T47.3 Saline and osmotic laxatives	0.000	0.992	0.007
C46.9 Kaposi's sarcoma, unspecified	0.000	0.993	0.007
C46.8 Kaposi's sarcoma of multiple organs	0.000	0.993	0.007
C46.7 Kaposi's sarcoma of other sites	0.000	0.993	0.007
C46.3 Kaposi's sarcoma of lymph nodes	0.000	0.993	0.007
C46.2 Kaposi's sarcoma of palate	0.000	0.993	0.007
C46.1 Kaposi's sarcoma of soft tissue	0.000	0.993	0.007
C46.0 Kaposi's sarcoma of skin	0.000	0.993	0.007
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.000	0.993	0.007
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.000	0.993	0.007
C47.6 Peripheral nerves of trunk, unspecified	0.000	0.993	0.007
C47.5 Peripheral nerves of pelvis	0.000	0.993	0.007
C47.4 Peripheral nerves of abdomen	0.000	0.993	0.007
C47.3 Peripheral nerves of thorax	0.000	0.993	0.007
C47.2 Peripheral nerves of lower limb, including hip	0.000	0.993	0.007
C47.1 Peripheral nerves of upper limb, including shoulder	0.000	0.993	0.007
C47.0 Peripheral nerves of head, face and neck	0.000	0.993	0.007
T38.1 Thyroid hormones and substitutes	0.000	0.993	0.007
T36 Poisoning by systemic antibiotics	0.000	0.993	0.007
Z91.5 Personal history of self-harm	0.000	0.993	0.007
C49.3 Connective and soft tissue of thorax	0.000	0.993	0.007
T38.5 Other oestrogens and progestogens	0.000	0.993	0.007
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.000	0.993	0.007
I42.7 Cardiomyopathy due to drugs and other external agents	0.007	0.993	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.993	0.007
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.993	0.007
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.993	0.007
C49.8 Overlapping lesion of connective and soft tissue	0.000	0.993	0.007
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.993	0.007
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.000	0.993	0.007
T42.1 Iminostilbenes	0.000	0.993	0.007
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.993	0.007
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.993	0.007
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.993	0.007
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.993	0.007
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.993	0.007
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.993	0.007
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.993	0.007
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.993	0.007
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.993	0.007
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.993	0.007
T44.0 Anticholinesterase agents	0.000	0.993	0.007
T41.5 Therapeutic gases	0.000	0.993	0.006
T41.4 Anaesthetic, unspecified	0.000	0.993	0.006
T41.3 Local anaesthetics	0.000	0.993	0.006
T41.2 Other and unspecified general anaesthetics	0.000	0.993	0.006
T41.1 Intravenous anaesthetics	0.000	0.993	0.006
T41.0 Inhaled anaesthetics	0.000	0.993	0.006
I42.3 Endomyocardial (eosinophilic) disease	0.007	0.993	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.993	0.006
T48.4 Expectorants	0.000	0.993	0.006
T48.3 Antitussives	0.000	0.993	0.006
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.993	0.006
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.993	0.006
T48.0 Oxytocic drugs	0.000	0.993	0.006
I42.5 Other restrictive cardiomyopathy	0.006	0.993	0.000
S61.1 Open wound of finger(s) with damage to nail	0.007	0.993	0.000
I42.0 Dilated cardiomyopathy	0.007	0.993	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.993	0.006
T45.2 Vitamins, not elsewhere classified	0.000	0.994	0.006
I42.8 Other cardiomyopathies	0.006	0.994	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.994	0.006
T42.2 Succinimides and oxazolidinediones	0.000	0.994	0.006
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.994	0.006
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.994	0.006
T47.4 Other laxatives	0.000	0.994	0.006
C49.2 Connective and soft tissue of lower limb, including hip	0.000	0.994	0.006
J35 Chronic diseases of tonsils and adenoids	0.000	0.994	0.006
J35.2 Hypertrophy of adenoids	0.000	0.994	0.006
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.994	0.006
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.006	0.994	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.000	0.994	0.006
T42.3 Barbiturates	0.000	0.994	0.006
T49.9 Topical agent, unspecified	0.000	0.994	0.006
T49.8 Other topical agents	0.000	0.994	0.006
T49.7 Dental drugs, topically applied	0.000	0.994	0.006
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.994	0.006
T49.5 Ophthalmological drugs and preparations	0.000	0.994	0.006
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.994	0.006
T49.3 Emollients, demulcents and protectants	0.000	0.994	0.006
T49.2 Local astringents and local detergents	0.000	0.994	0.006
T49.1 Antipruritics	0.000	0.994	0.006
C49.1 Connective and soft tissue of upper limb, including shoulder	0.000	0.994	0.006
T48.5 Anti-common-cold drugs	0.000	0.994	0.005
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.994	0.006
T36.4 Tetracyclines	0.000	0.994	0.005
K12.3 Oral mucositis (ulcerative)	0.006	0.994	0.000
D61.9 Aplastic anaemia, unspecified	0.006	0.994	0.000
H69.9 Eustachian tube disorder, unspecified	0.006	0.994	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.994	0.005
T36.8 Other systemic antibiotics	0.000	0.994	0.005
T36.7 Antifungal antibiotics, systemically used	0.000	0.994	0.005
T36.6 Rifamycins	0.000	0.994	0.005
T36.5 Aminoglycosides	0.000	0.994	0.005
T36.2 Chloramphenicol group	0.000	0.994	0.005
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.994	0.005
T42.4 Benzodiazepines	0.000	0.994	0.006
T50.4 Drugs affecting uric acid metabolism	0.000	0.994	0.005
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.994	0.006
D35.0 Adrenal gland	0.000	0.994	0.006
T36.3 Macrolides	0.000	0.994	0.005
J35.1 Hypertrophy of tonsils	0.000	0.994	0.005
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.995	0.005
T45.8 Other primarily systemic and haematological agents	0.000	0.995	0.005
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.995	0.005
T45.6 Fibrinolysis-affecting drugs	0.000	0.995	0.005
T45.4 Iron and its compounds	0.000	0.995	0.005
T45.3 Enzymes, not elsewhere classified	0.000	0.995	0.005
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.005	0.995	0.000
T50.7 Analeptics and opioid receptor antagonists	0.000	0.995	0.005
T50.5 Appetite depressants	0.000	0.995	0.005
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.995	0.005
T50.1 Loop [high-ceiling] diuretics	0.000	0.995	0.005
T50.0 Mineralocorticoids and their antagonists	0.000	0.995	0.005
D35.1 Parathyroid gland	0.000	0.995	0.005
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.000	0.995	0.005
H25.0 Senile incipient cataract	0.000	0.995	0.005
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.995	0.005
K81.0 Acute cholecystitis	0.005	0.995	0.000
D35 Benign neoplasm of other and unspecified endocrine glands	0.000	0.995	0.005
C49.9 Connective and soft tissue, unspecified	0.000	0.995	0.005
Z71.8 Other specified counselling	0.005	0.995	0.000
T45.5 Anticoagulants	0.000	0.995	0.005
J35.9 Chronic disease of tonsils and adenoids, unspecified	0.000	0.995	0.005
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.995	0.005
D35.2 Pituitary gland	0.000	0.995	0.005
J35.3 Hypertrophy of tonsils with hypertrophy of adenoids	0.000	0.995	0.005
T45.0 Antiallergic and antiemetic drugs	0.000	0.995	0.005
C85.0 Lymphosarcoma	0.005	0.995	0.000
W19.1 Residential institution	0.005	0.995	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.004	0.995	0.000
W19 Unspecified fall	0.005	0.995	0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.995	0.005
T40.6 Other and unspecified narcotics	0.000	0.995	0.004
I42.6 Alcoholic cardiomyopathy	0.004	0.996	0.000
T42.0 Hydantoin derivatives	0.000	0.996	0.004
H69.8 Other specified disorders of Eustachian tube	0.004	0.996	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.000	0.996	0.004
T50.8 Diagnostic agents	0.000	0.996	0.004
T40.1 Heroin	0.000	0.996	0.004
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.996	0.004
T40.8 Lysergide [LSD]	0.000	0.996	0.004
T40.7 Cannabis (derivatives)	0.000	0.996	0.004
T40.3 Methadone	0.000	0.996	0.004
T40.0 Opium	0.000	0.996	0.004
H69 Other disorders of Eustachian tube	0.004	0.996	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
Z45.8 Adjustment and management of other implanted devices	0.004	0.996	0.000
T36.0 Penicillins	0.000	0.996	0.004
Y45.5 4-Aminophenol derivatives	0.000	0.996	0.004
D35.9 Endocrine gland, unspecified	0.000	0.996	0.004
D35.8 Pluriglandular involvement	0.000	0.996	0.004
D35.7 Other specified endocrine glands	0.000	0.996	0.004
D35.6 Aortic body and other paraganglia	0.000	0.996	0.004
D35.5 Carotid body	0.000	0.996	0.004
D35.4 Pineal gland	0.000	0.996	0.004
D35.3 Craniopharyngeal duct	0.000	0.996	0.004
J35.8 Other chronic diseases of tonsils and adenoids	0.000	0.996	0.004
T40.5 Cocaine	0.000	0.996	0.003
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
K31.9 Disease of stomach and duodenum, unspecified	0.000	0.996	0.004
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.996	0.003
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.996	0.004
D50.8 Other iron deficiency anaemias	0.004	0.996	0.000
Y45.8 Other analgesics and antipyretics	0.000	0.996	0.003
W19.8 Other specified place	0.003	0.996	0.000
W19.5 Trade and service area	0.003	0.996	0.000
W19.0 Home	0.003	0.996	0.000
W19.7 Farm	0.003	0.996	0.000
Y45.4 Antirheumatics	0.000	0.997	0.003
C83.3 Large cell (diffuse)	0.003	0.997	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
W19.3 Sports and athletics area	0.003	0.997	0.000
H69.0 Patulous Eustachian tube	0.003	0.997	0.000
Z74.1 Need for assistance with personal care	0.003	0.997	0.000
W19.6 Industrial and construction area	0.003	0.997	0.000
T40.4 Other synthetic narcotics	0.000	0.997	0.003
Y42.4 Oral contraceptives	0.003	0.997	0.000
Y42.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
Z71.3 Dietary counselling and surveillance	0.003	0.997	0.000
T39.0 Salicylates	0.000	0.997	0.003
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.000	0.997	0.003
C85.7 Other specified types of non-Hodgkin's lymphoma	0.003	0.997	0.000
Y42.5 Other oestrogens and progestogens	0.003	0.997	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history	0.000	0.997	0.003
T39.4 Antirheumatics, not elsewhere classified	0.000	0.997	0.003
T39.2 Pyrazolone derivatives	0.000	0.997	0.003
Z86.3 Personal history of endocrine, nutritional and metabolic diseases	0.000	0.997	0.003
W19.09 Unspecified fall; Home; During unspecified activity	0.003	0.997	0.000
W19.08 Unspecified fall; Home; While engaged in other specified activities	0.003	0.997	0.000
W19.59 Unspecified fall; Trade and service area; During unspecified activity	0.003	0.997	0.000
W19.81 Unspecified fall; Other specified places; While engaged in leisure activity	0.003	0.997	0.000
Y42.2 Antithyroid drugs	0.003	0.997	0.000
R68.0 Hypothermia, not associated with low environmental temperature	0.003	0.997	0.000
M06.49 Inflammatory polyarthropathy (Site unspecified)	0.000	0.997	0.003
Z32.1 Pregnancy confirmed	0.000	0.997	0.003
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues	0.003	0.997	0.000
J32.0 Chronic maxillary sinusitis	0.000	0.997	0.003
T40.2 Other opioids	0.000	0.997	0.003
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified	0.003	0.997	0.000
Y42.1 Thyroid hormones and substitutes	0.002	0.997	0.000
D61 Other aplastic anaemias	0.003	0.997	0.000
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.000	0.997	0.003
M06 Other rheumatoid arthritis	0.000	0.997	0.003
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.997	0.002
L91.0 Keloid scar	0.000	0.997	0.003
Y45.2 Propionic acid derivatives	0.000	0.997	0.002
Y45.1 Salicylates	0.000	0.998	0.002
M06.4 Inflammatory polyarthropathy	0.000	0.998	0.002
O90.8 Other complications of the puerperium, not elsewhere classified	0.000	0.998	0.002
J11.1 Influenza with other respiratory manifestations, virus not identified	0.002	0.998	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.002	0.998	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.002	0.998	0.000
M06.8 Other specified rheumatoid arthritis	0.000	0.998	0.002
R68.8 Other specified general symptoms and signs	0.002	0.998	0.000
D61.0 Constitutional aplastic anaemia	0.002	0.998	0.000
L60.0 Ingrowing nail	0.000	0.998	0.002
W17.4 Street and highway	0.002	0.998	0.000
T39.1 4-Aminophenol derivatives	0.000	0.998	0.002
Z04.3 Examination and observation following other accident	0.002	0.998	0.000
W17.2 School, other institution and public administrative area	0.002	0.998	0.000
Y42.7 Androgens and anabolic congeners	0.002	0.998	0.000
Z71.4 Alcohol abuse counselling and surveillance	0.002	0.998	0.000
Z74 Problems related to care-provider dependency	0.002	0.998	0.000
Z71.7 Human immunodeficiency virus [HIV] counselling	0.002	0.998	0.000
Z71.5 Drug abuse counselling and surveillance	0.002	0.998	0.000
Z71.0 Person consulting on behalf of another person	0.002	0.998	0.000
M06.89 Other specified rheumatoid arthritis (Site unspecified)	0.000	0.998	0.002
M79.60 Pain in limb (Multiple sites)	0.002	0.998	0.000
L28.0 Lichen simplex chronicus	0.002	0.998	0.000
D61.8 Other specified aplastic anaemias	0.002	0.998	0.000
D61.3 Idiopathic aplastic anaemia	0.002	0.998	0.000
D61.2 Aplastic anaemia due to other external agents	0.002	0.998	0.000
R27.0 Ataxia, unspecified	0.000	0.998	0.002
Z71.2 Person consulting for explanation of investigation findings	0.002	0.998	0.000
N75 Diseases of Bartholin's gland	0.002	0.998	0.000
R68 Other general symptoms and signs	0.002	0.998	0.000
M06.2 Rheumatoid bursitis	0.000	0.998	0.002
M06.1 Adult-onset Still's disease	0.000	0.998	0.002
W17 Other fall from one level to another	0.002	0.998	0.000
C62.9 Testis, unspecified	0.000	0.998	0.002
Z74.3 Need for continuous supervision	0.002	0.998	0.000
C83.5 Lymphoblastic (diffuse)	0.002	0.998	0.000
M06.46 Inflammatory polyarthropathy (Lower leg)	0.000	0.998	0.002
C83.7 Burkitt's tumour	0.002	0.998	0.000
S32.10 Fracture of sacrum (closed)	0.000	0.998	0.002
M06.48 Inflammatory polyarthropathy (Other)	0.000	0.998	0.002
M06.47 Inflammatory polyarthropathy (Ankle and foot)	0.000	0.998	0.002
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)	0.000	0.998	0.002
M06.44 Inflammatory polyarthropathy (Hand)	0.000	0.998	0.002
M06.43 Inflammatory polyarthropathy (Forearm)	0.000	0.998	0.002
M06.42 Inflammatory polyarthropathy (Upper arm)	0.000	0.998	0.002
M06.41 Inflammatory polyarthropathy (Shoulder region)	0.000	0.998	0.002
B35.3 Tinea pedis	0.000	0.998	0.002
Z74.0 Reduced mobility	0.002	0.998	0.000
C83.6 Undifferentiated (diffuse)	0.002	0.998	0.000
C83.4 Immunoblastic (diffuse)	0.002	0.998	0.000
C83.2 Mixed small and large cell (diffuse)	0.002	0.998	0.000
D61.1 Drug-induced aplastic anaemia	0.002	0.998	0.000
Z35.0 Supervision of pregnancy with history of infertility	0.000	0.998	0.002
C77.4 Inguinal and lower limb lymph nodes	0.002	0.998	0.000
M06.88 Other specified rheumatoid arthritis (Other)	0.000	0.998	0.002
M06.87 Other specified rheumatoid arthritis (Ankle and foot)	0.000	0.998	0.002
M06.86 Other specified rheumatoid arthritis (Lower leg)	0.000	0.998	0.002
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)	0.000	0.998	0.002
M06.84 Other specified rheumatoid arthritis (Hand)	0.000	0.998	0.002
M06.83 Other specified rheumatoid arthritis (Forearm)	0.000	0.998	0.002
M06.82 Other specified rheumatoid arthritis (Upper arm)	0.000	0.998	0.002
M06.81 Other specified rheumatoid arthritis (Shoulder region)	0.000	0.998	0.002
M06.80 Other specified rheumatoid arthritis (Multiple sites)	0.000	0.998	0.002
O69.8 Labour and delivery complicated by other cord complications	0.000	0.998	0.002
W17.3 Sports and athletics area	0.002	0.998	0.000
R68.2 Dry mouth, unspecified	0.002	0.998	0.000
N75.8 Other diseases of Bartholin's gland	0.002	0.998	0.000
R68.3 Clubbing of fingers	0.002	0.998	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.998	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.002	0.998	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.998	0.001
R39 Other symptoms and signs involving the urinary system	0.000	0.998	0.002
K65.8 Other peritonitis	0.002	0.998	0.000
N75.9 Disease of Bartholin's gland, unspecified	0.002	0.998	0.000
O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium	0.000	0.998	0.002
R68.1 Nonspecific symptoms peculiar to infancy	0.002	0.998	0.000
M06.19 Adult-onset Still's disease (Site unspecified)	0.000	0.998	0.002
M06.18 Adult-onset Still's disease (Other)	0.000	0.998	0.002
M06.17 Adult-onset Still's disease (Ankle and foot)	0.000	0.998	0.002
M06.16 Adult-onset Still's disease (Lower leg)	0.000	0.998	0.002
M06.15 Adult-onset Still's disease (Pelvic region and thigh)	0.000	0.998	0.002
M06.14 Adult-onset Still's disease (Hand)	0.000	0.998	0.002
M06.13 Adult-onset Still's disease (Forearm)	0.000	0.998	0.002
M06.12 Adult-onset Still's disease (Upper arm)	0.000	0.998	0.002
M06.11 Adult-onset Still's disease (Shoulder region)	0.000	0.998	0.002
M06.10 Adult-onset Still's disease (Multiple sites)	0.000	0.998	0.002
M06.29 Rheumatoid bursitis (Site unspecified)	0.000	0.998	0.002
M06.28 Rheumatoid bursitis (Other)	0.000	0.998	0.002
M06.27 Rheumatoid bursitis (Ankle and foot)	0.000	0.998	0.002
M06.26 Rheumatoid bursitis (Lower leg)	0.000	0.998	0.002
M06.25 Rheumatoid bursitis (Pelvic region and thigh)	0.000	0.998	0.002
M06.24 Rheumatoid bursitis (Hand)	0.000	0.998	0.002
M06.23 Rheumatoid bursitis (Forearm)	0.000	0.998	0.002
M06.22 Rheumatoid bursitis (Upper arm)	0.000	0.998	0.002
M06.21 Rheumatoid bursitis (Shoulder region)	0.000	0.998	0.002
M06.20 Rheumatoid bursitis (Multiple sites)	0.000	0.998	0.002
W17.9 Unspecified place	0.002	0.998	0.000
W17.8 Other specified place	0.002	0.998	0.000
W17.0 Home	0.002	0.998	0.000
W17.7 Farm	0.002	0.998	0.000
W17.1 Residential institution	0.002	0.998	0.000
Z87.7 Personal history of congenital malformations, deformations and chromosomal abnormalities	0.000	0.998	0.002
W07.9 Unspecified place	0.002	0.998	0.000
C83.1 Small cleaved cell (diffuse)	0.002	0.998	0.000
Z35.9 Supervision of high-risk pregnancy, unspecified	0.000	0.998	0.002
C86 Other specified types of T/NK-cell lymphoma	0.002	0.998	0.000
Z84.8 Family history of other specified conditions	0.000	0.998	0.002
O90 Complications of the puerperium, not elsewhere classified	0.000	0.998	0.002
C32.0 Glottis	0.000	0.998	0.002
C83.0 Small cell (diffuse)	0.002	0.998	0.000
W15 Fall from cliff	0.002	0.998	0.000
Z71.9 Counselling, unspecified	0.002	0.998	0.000
Z74.8 Other problems related to care-provider dependency	0.002	0.998	0.000
W15.9 Unspecified place	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.000	0.998	0.002
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
O90.1 Disruption of perineal obstetric wound	0.000	0.998	0.002
Z74.2 Need for assistance at home and no other household member able to render care	0.002	0.998	0.000
W00-W19 Falls	0.002	0.998	0.000
O90.9 Complication of the puerperium, unspecified	0.000	0.998	0.002
B18.1 Chronic viral hepatitis B without delta-agent	0.002	0.998	0.000
T80.1 Vascular complications following infusion, transfusion and therapeutic injection	0.002	0.998	0.000
W17.5 Trade and service area	0.001	0.998	0.000
L91.8 Other hypertrophic disorders of skin	0.000	0.998	0.002
Z74.9 Problem related to care-provider dependency, unspecified	0.001	0.998	0.000
Z35 Supervision of high-risk pregnancy	0.000	0.998	0.002
M72.27 Plantar fascial fibromatosis-Ankle/Foot	0.002	0.998	0.000
F60.9 Personality disorder, unspecified	0.000	0.998	0.002
O42.9 Premature rupture of membranes, unspecified	0.000	0.998	0.002
W19.4 Street and highway	0.002	0.998	0.000
Z35.4 Supervision of pregnancy with grand multiparity	0.000	0.998	0.002
W15.8 Other specified place	0.001	0.998	0.000
C94 Other leukaemias of specified cell type	0.001	0.998	0.000
R39.2 Extrarenal uraemia	0.000	0.998	0.001
S30.0 Contusion of lower back and pelvis	0.002	0.998	0.000
W17.6 Industrial and construction area	0.001	0.998	0.000
L91 Hypertrophic disorders of skin	0.000	0.998	0.002
W17.09 Other fall from one level to another, Home , During unspecified activity	0.001	0.998	0.000
W17.81 Other fall from one level to another; Other specified places; While engaged in leisure activity	0.001	0.998	0.000
W17.99 Other fall from one level to another; Unspecified place; During unspecified activity	0.001	0.998	0.000
W07.8 Other specified place	0.001	0.998	0.000
W08 Fall involving other furniture	0.001	0.998	0.000
M06.40 Inflammatory polyarthropathy (Multiple sites)	0.000	0.998	0.001
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.001	0.998	0.000
C86.4 Blastic NK-cell lymphoma	0.001	0.998	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.001	0.998	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.001	0.998	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.001	0.998	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.001	0.998	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.001	0.998	0.000
O69.1 Labour and delivery complicated by cord around neck, with compression	0.000	0.998	0.002
W08.0 Home	0.001	0.998	0.000
W16 Diving or jumping into water causing injury other than drowning or submersion	0.001	0.998	0.000
W07 Fall involving chair	0.001	0.998	0.000
C91.9 Lymphoid leukaemia, unspecified	0.001	0.998	0.000
O90.5 Postpartum thyroiditis	0.000	0.998	0.001
O90.4 Postpartum acute renal failure	0.000	0.998	0.001
O90.3 Cardiomyopathy in the puerperium	0.000	0.998	0.001
W15.7 Farm	0.001	0.998	0.000
W15.6 Industrial and construction area	0.001	0.998	0.000
W15.5 Trade and service area	0.001	0.998	0.000
W15.4 Street and highway	0.001	0.998	0.000
W15.3 Sports and athletics area	0.001	0.998	0.000
W15.2 School, other institution and public administrative area	0.001	0.998	0.000
W15.1 Residential institution	0.001	0.998	0.000
W15.0 Home	0.001	0.998	0.000
M79.83 Other specified soft tissue disorders (Forearm)	0.001	0.999	0.000
C82.0 Small cleaved cell, follicular	0.001	0.999	0.000
Y88.3 Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient or of later complication, without mention of misadventure at the time of the procedure	0.001	0.999	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.001	0.999	0.000
W12 Fall on and from scaffolding	0.001	0.999	0.000
W04 Fall while being carried or supported by other persons	0.001	0.999	0.000
M24.41 Recurrent dislocation and subluxation of joint (Shoulder region)	0.000	0.999	0.001
W11.2 School, other institution and public administrative area	0.001	0.999	0.000
W00 Fall on same level involving ice and snow	0.001	0.999	0.000
C92.1 Chronic myeloid leukaemia	0.001	0.999	0.000
F33.1 Recurrent depressive disorder, current episode moderate	0.000	0.999	0.001
G50.1 Atypical facial pain	0.000	0.999	0.001
H52.1 Myopia	0.000	0.999	0.001
W14 Fall from tree	0.001	0.999	0.000
M79.84 Other specified soft tissue disorders (Hand)	0.001	0.999	0.000
C15.9 Oesophagus, unspecified	0.000	0.999	0.001
H58.8 Visual disturbances in diseases classified elsewhere	0.000	0.999	0.001
L91.9 Hypertrophic disorder of skin, unspecified	0.000	0.999	0.001
O90.2 Haematoma of obstetric wound	0.000	0.999	0.001
W10.1 Residential institution	0.001	0.999	0.000
W16.9 Unspecified place	0.001	0.999	0.000
Z35.7 Supervision of high-risk pregnancy due to social problems	0.000	0.999	0.001
Z35.6 Supervision of very young primigravida	0.000	0.999	0.001
Z35.3 Supervision of pregnancy with history of insufficient antenatal care	0.000	0.999	0.001
C91 Lymphoid leukaemia	0.001	0.999	0.000
C94.7 Other specified leukaemias	0.001	0.999	0.000
C94.5 Acute myelofibrosis	0.001	0.999	0.000
C94.4 Acute panmyelosis	0.001	0.999	0.000
C94.3 Mast cell leukaemia	0.001	0.999	0.000
C94.2 Acute megakaryoblastic leukaemia	0.001	0.999	0.000
C94.1 Chronic erythraemia	0.001	0.999	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.001	0.999	0.000
Z71.6 Tobacco abuse counselling	0.001	0.999	0.000
C93 Monocytic leukaemia	0.001	0.999	0.000
W02 Fall involving ice-skates, skis, roller-skates or skateboards	0.001	0.999	0.000
G31.2 Degeneration of nervous system due to alcohol	0.000	0.999	0.001
O63.0 Prolonged first stage (of labour)	0.000	0.999	0.001
O90.0 Disruption of Caesarean section wound	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations